Cite
HARVARD Citation
Engel-Riedel, W. et al. (2018). A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer. Journal for immunotherapy of cancer. 6 (1), p. . [Online].